Genomics, proteomics and molecular biology lead to tremendous advances in all fields of
medical sciences. Among these the finding of biomarkers as non invasive indicators of …

Currently trials of immunosuppression in transplantation are in decline because their
objectives remain focused on improving acute rejection rates and graft survival in the first 12 …

Background Immunosuppression nonadherence increases the risk for kidney transplant loss
after transplantation. Wireless-enabled pill bottles have created the opportunity to monitor …

Kidney transplantation (KTx) represents the best available treatment for patients with end-
stage renal disease. Still, full benefits of KTx are undermined by acute rejection (AR). The …

Biomarker profiles of acute rejection in liver transplant recipients could enhance the
diagnosis and management of recipients. Our aim was to identify diagnostic proteoform …

Kidney transplantation (KTx) represents the best available treatment for patients with end-
stage renal disease. Still, the full benefits of KTx are undermined by acute rejection (AR) …

We performed orthogonal technology comparisons of concurrent peripheral blood and
biopsy tissue samples from 69 kidney transplant recipients who underwent comprehensive …

Over the last> 20 years, we have co‐developed the rationale for the first diagnostic and
prognostic leukocyte gene expression profiling (GEP) biomarker test in transplantation …

Acute rejection is one of the major immunological determinants of kidney graft function and
survival. Early biomarkers to predict rejection are lacking. Emerging evidence reveals a …

Abstract Background/Aims: Acute rejection (AR) is a major complication post renal
transplantation, with no widely-accepted non-invasive biomarker. This study aimed to …